Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$12.38 - $17.47 $136,340 - $192,397
-11,013 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$12.27 - $15.79 $49,767 - $64,044
4,056 Added 58.3%
11,013 $146,000
Q2 2019

Aug 12, 2019

SELL
$13.37 - $18.85 $19,948 - $28,124
-1,492 Reduced 17.66%
6,957 $98,000
Q1 2019

Apr 29, 2019

BUY
$17.59 - $31.05 $148,617 - $262,341
8,449 New
8,449 $155,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $299M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.